Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease
Emanuel Della‐Torre, Marco Lanzillotta, Tommaso Germanò, Gaia Mancuso, Giuseppe A. Ramirez, Gabriele Capurso, Massimo Falconi, Lorenzo Dagna
Topics & Concepts
MedicineRituximabDiseaseIgG4-related diseaseMedical diagnosisInternal medicinePhysical therapyPathologyLymphomaIgG4-Related and Inflammatory DiseasesNeuroendocrine Tumor Research AdvancesGastrointestinal disorders and treatments